PRGO

#1729
PERRIGO COMPANY PLC
13.2050
-5.00%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
13.2025
13.4000
Jahresspanne
12.1700
22.0100
Tagesänderung
-5.00%
Monatliche Änderung
-5.68%
6 month change
-38.64%
Jahresänderung
-38.64%
Vorheriger Schlusskurs
13.9000
Open
13.3750
Bid
Ask
Low
13.2025
High
13.4000
Volumen
2 174
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.8289 B
  • Employee 8 379
  • Founded N/A
  • CEO Murray S. Kessler
  • Website www.perrigo.com
  • Headquarter Ireland
  • FIGI N/A
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.35
Price to sales ratio
—
Dividends per share
1.16
Dividend yield %
8.33

Perrigo Company plc

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

Nachrichten